Economía de los medicamentos genéricos en América Latina / Economy of generic drugs in Latin America
Rev. panam. salud pública
; 23(1): 59-67, ene. 2008.
Article
de Es
| LILACS
| ID: lil-478912
Bibliothèque responsable:
BR1.1
ABSTRACT
In terms of economics, implementing generic drug policy is nothing other than consolidating (or even, creating) drug markets that set competitive prices, the result of which favors public access to essential drugs. This article approaches the topic of generic drugs from the economic perspective by examining various regulatory models in order to evaluate and leverage generic drug policy implementation options as a mechanism for battling some of the markets specific weaknesses. The conclusion is that there is no single unequivocal method for promoting the use of generic drugs, and that the most favorable way to integrate markets may be through a broad combination of alternatives. These alternatives are grouped and analyzed according to the market issues or challenges that must be overcome. Several options are then identified based on the degree of market consolidation to be obtained.
Mots clés
Texte intégral:
1
Indice:
LILACS
Sujet Principal:
Médicaments génériques
Type d'étude:
Evaluation_studies
/
Health_economic_evaluation
Limites du sujet:
Humans
langue:
Es
Texte intégral:
Rev. panam. salud pública
Thème du journal:
SAUDE PUBLICA
Année:
2008
Type:
Article